Role of increasing protein intake and correction of micronutrients imbalance to promote desired autophagy in treating resistant dermatophyte infection: A cohort of 62 patients
Main Article Content
Abstract
Background: Chronic and recurrent dermatophytosis is being increasingly reported worldwide, posing significant therapeutic challenges. Emerging evidence suggests a potential role of host factors, including nutritional status and autophagy, in disease persistence.
Objective: To evaluate the clinical, nutritional, and biochemical profiles of patients with recalcitrant dermatophytosis and assess treatment outcomes following systemic antifungal therapy combined with protein and micronutrient supplementation.
Methods: A retrospective chart review of 62 patients with recalcitrant dermatophytosis was conducted. A subgroup (n=17) underwent detailed nutritional and biochemical assessment. All patients received oral itraconazole, and those with deficiencies were provided dietary counselling, protein and micronutrient supplementation.
Results: Protein deficiency was observed in all patients assessed, with 58.8% consuming <50% of daily protein requirements. Vitamin D3 deficiency (82.3%) and low serum ferritin (76.5%) were prevalent. Comorbidities like diabetes and dyslipidemia were also noted. Clinical cure was achieved in 83.87% of patients, with recurrences in only 6.5% patients over period of one year linked to poor compliance or use of alternative therapies.
Conclusion: Host nutritional deficiencies, particularly in protein and iron, may contribute to deregulated autophagy and persistent dermatophytosis. Addressing these deficits alongside antifungal therapy improves treatment outcomes and reduces relapse risk. Evaluation for protein and micronutrient deficiencies and corrective measures should be integrated into the management protocols for recalcitrant dermatophytosis.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Indian Council of Medical Research–National Institute of Nutrition. (2017). Indian food composition tables. Hyderabad: National Institute of Nutrition, ICMR.
3. Indian Council of Medical Research–National Institute of Nutrition, Expert Group. (2020). Nutrient requirements for Indians: Recommended dietary allowances and estimated average requirements. Hyderabad: National Institute of Nutrition, ICMR.
4. Medindia. Protein Intake Calculator [Internet]. Chennai: Medindia; 2024 [cited 2025 Aug 29]. Available from: https://www.medindia.net/patients/calculators/protein-intake-calculator.asp
5. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008 Sep;51 Suppl 4:2–15.
6. Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features. Indian J Dermatol Venereol Leprol. 2021;87(2):154–75.
7. Deng R, Wang X, Li R. Dermatophyte infection: from fungal pathogenicity to host immune responses. Front Immunol. 2023 Nov 2;14:1285887.
8. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, et al. Human Dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med. 2009 Oct 29;361(18):1760–7.
9. Lanternier F, Mahdaviani SA, Barbati E, Koumar Y, Levy R, Ghandil P, et al. Frequency and geographic distribution of CARD9 mutations in patients with severe fungal infections. Front Microbiol. 2018 Oct 9;9:2196.
10. Rai G, Das S, Ansari MA, Singh PK, Pandhi D, Tigga RA, et al. The interplay among Th17 and T regulatory cells in the immune dysregulation of chronic dermatophytic infection. Microb Pathog. 2020 Feb;139:103921.
11. García-Romero MT, Arenas R. New insights into genes, immunity, and the occurrence of dermatophytosis. J Invest Dermatol. 2015 Mar;135(3):655–7.
12. Chai LYA, Netea MG, Vonk AG, Kullberg BJ. Fungal strategies for overcoming host innate immune response. Med Mycol. 2009 May;47(3):227–36.
13. Collette JR, Lorenz MC. Mechanisms of immune evasion in fungal pathogens. Curr Opin Microbiol. 2011 Dec;14(6):668–75.
14. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy: renovation of cells and tissues. Cell. 2008 Nov 28;132(4):697–710.
15. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol. 2004 Dec;16(6):663–9.
16. Kroemer G, Levine B. Autophagy: dual roles in life and death? Nat Rev Mol Cell Biol. 2008 Jun;9(6):505–14.
17. White E. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer. 2012 Jun;12(6):401–10.
18. Garg S, Sangwan A. Dietary protein deficit and deregulated autophagy: a new clinico-diagnostic perspective in pathogenesis of early aging, skin, and hair disorders. Indian Dermatol Online J. 2019; 10(2):115–24.
19. Nicola AM, Albuquerque P, Martinez LR, Dal-Rosso RA, Saylor C, De Jesus M, et al. Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun. 2012 Sep; 80(9):3065–76.
20. Kanayama M, Inoue M, Danzaki K, Hammer G, He YW, Shinohara ML. Autophagy enhances NF-κB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015 Jan;6:5779.
21. Masperi P, Dall’Olio G, Calefano A, Vannini GL. Autophagic vacuole development in Trichophyton mentagrophytes exposed in vitro to miconazole. Sabouraudia. 1984;22(1):27–35.
22. Afzal O, Altamimi ASA, Mubeen B, Alzarea SI, Almalki WH, Al-Qahtani SD, et al. mTOR as a potential target for the treatment of microbial infections, inflammatory bowel diseases, and colorectal cancer. Int J Mol Sci. 2022 Oct 18; 23(20):12470.
23. Garg S, Sangwan A. Reversal and prevention of deregulated autophagy and its role in skin and hair disorders. Pigment Int. 2024;11(1):10–17.
24. Kim J, Kundu M, Viollet B, Guan KL. The mTOR –autophagy axis and the control of metabolism. Front Cell Dev Biol. 2021 Apr;9:655731.
25. Almeida RS, Wilson D, Hube B. Candida albicans iron acquisition within the host. FEMS Yeast Res. 2009 Nov;9(7):1000–12.
26. Cassat JE, Skaar EP. Iron in infection and immunity. Cell Host Microbe. 2013 May 15;13(5):509–19.
27. King RD, Khan HA, Foye JC, Greenberg JH, Jones HE. Transferrin, iron, and dermatophytes. I. Serum dermatophyte inhibitory component definitively identified as unsaturated transferrin. J Lab Clin Med. 1975 Aug;86(2):204–12.
28. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta. 2005 Dec;1754(1):253–62.
29. Jartarkar SR, Patil A, Goldust Y, Cockerell CJ, Schwartz RA, Grabbe S, et al. Pathogenesis, immunology and management of dermatophytosis. J Fungi. 2022;8(1):39.
30. Hennigar SR, McClung JP. Nutritional immunity. Am J Lifestyle Med. 2016 May-Jun;10(3):170–3.
31. Gozzelino R, Arosio P. Iron homeostasis in health and disease. Int J Mol Sci. 2016 Jan;17(1):130.
32. Drakesmith H, Prentice AM. Hepcidin and the iron-infection axis. Science. 2012 Nov 9;338 (6108):768–72.
33. Kechichian E, Ezzedine K. Vitamin D and the skin: an update for dermatologists. Am J Clin Dermatol. 2018 Apr;19(2):223–35.
34. Raja SK, GH S. Serum vitamin D3 deficiency among cases with extensive tinea corporis infection. Int J Res Dermatol. 2020;6(6):729-732. doi:10.1820 3/issn.2455-4529.IntJResDermatol20203962